Revive Therapeutics Announces Results of Phase 3 Clinical Study for Bucillamine...

Psychedelic Research Bulletin: June 2023

American Medical Association Releases Language of First New Current Procedural Terminology...

PT421 – The Impact of the Therapeutic Alliance on the Psychedelic...

FILAMENT HEALTH TO SUPPLY PSILOCYBIN FOR RECIPIENTS OF THE CANADIAN INSTITUTES...

COMPASS Pathways Secures Term Loan Facility for Up to $50 Million...

Small Pharma Announces SPL028 R&D Strategy Update

Wesana Health Announces Closing of Previously Announced SANA-013 Asset Sale

Into the Psychedelic Practitioner Toolbox: Using a Transpersonal Approach

PT420 – DanceSafe: Drug Testing, Fentanyl Myths, and the Importance of...

Load more